Issue Date: March 13, 2017
Building pharmaceutical outsourcing partnerships
Throughout the U.S. presidential election season and into the Trump presidency, the high cost of drugs has made for heated discussion. A popular topic for pundits is the amount drug companies spend on marketing compared to the generally smaller sum they spend on research.
Little attention, though, is paid to what it costs them to manufacture their products. That’s in part because manufacturing is less glamorous than marketing and in part because . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society